Canada Markets closed

Helix BioPharma Corp. (HBPCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.25000.0000 (0.00%)
At close: 01:15PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.2500
Open0.2500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2500 - 0.2500
52 Week Range0.2500 - 0.8800
Volume75
Avg. Volume130
Market Cap35.488M
Beta (5Y Monthly)-0.11
PE Ratio (TTM)N/A
EPS (TTM)-0.0540
Earnings DateJun. 14, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Baystreet

    Stocks in play: Helix BioPharma Corp

    Is pleased to provide a corporate update on initiatives that were undertaken by the Company in 2021. ...

  • ACCESSWIRE

    Helix BioPharma Corp. Provides Corporate Update

    RICHMOND HILL, ON / ACCESSWIRE / December 31, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to provide a corporate update on initiatives that were undertaken by the Company in 2021.

  • ACCESSWIRE

    Helix Biopharma Corp. Announces Fiscal 2022 First Quarter Results

    RICHMOND HILL, ON / ACCESSWIRE / December 15, 2021 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced fiscal 2022 first quarter results for the period ending October 31, 2021.